Symtuza

(cobicistat / darunavir / emtricitabine / tenofovir alafenamide)

Symtuza 800 MG / 150 MG / 200 MG / 10 MG Oral Tablet

Dosage & administration

Testing: Prior to or when initiating SYMTUZA, test patients for HBV infection.

Prior to or when initiating SYMTUZA, and during treatment with SYMTUZA, on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients. In patients with chronic kidney disease, also assess serum phosphorus. ( 2.1)

Recommended dosage: One tablet taken once daily with food in adults and pediatric patients, weighing at least 40 kg. ( 2.2)

Renal Impairment: SYMTUZA is not recommended in patients with estimated creatinine clearance below 30 mL/min. ( 2.3)

Hepatic Impairment: SYMTUZA is not recommended in patients with severe hepatic impairment. ( 2.4)

drug label

Symtuza prescribing information

Contact Medical Science Liaison Report Adverse Event

samples

Request Symtuza samples

Online Sample Form

Learn More

prior authorization

Symtuza prior authorization resources

OTHERComplete Letter of Medical Necessity

PDFAppeals Considerations Checklist

PDFAppeals Considerations Checklist - Spanish

PDFFormulary Exception Request Letter

PDFFormulary Exception Request Letter - Spanish

PDFPA Checklist

Learn More

Benefits investigation

PDFBenefits Investigation Form

PDFJanssen Patient Support Program Patient Authorization Form

Learn More

financial assistance

Symtuza financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

J & J Patient Assistance Foundation Eligibility Check

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Symtuza patient education

Getting started on Symtuza

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link